Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 127
Filter
1.
J. optom. (Internet) ; 15(2): 1-6, April-June 2022.
Article in English | IBECS | ID: ibc-204570

ABSTRACT

Purpose: The use of swimming goggles (SG) has demonstrated to alter different ocular parameters, however, the impact of wearing SG on the tear film stability remain unknown. The main objective of this study was to determine the short-term effects of wearing SG on tear film surface quality break-up time (TFSQ-BUT).Methods: Twenty-eight young healthy adults (14 men and 14 women) wore a drilled SG, and TFSQ-BUT was measured before, during and after SG use. Dynamic-area high-speed videokeratoscopy was used for the non-invasive assessment of TFSQ-BUT.Results: TFSQ-BUT was significantly reduced while SG wear in comparison to the baseline measurement (4.8 ± 4.5 s vs. 8.8 ± 6.9 s; corrected p-value = 0.017, d = 0.57, mean difference = 4.0 [0.6, 7.3]; 45% reduction). Immediately after SG removal, TFSQ-BUT rapidly recovered baseline levels (8.2 ± 5.9 s vs. 8.8 ± 6.9 s; corrected p-value = 0.744). The impact of wearing SG on TFSQ-BUT were independent of the gender of the participants (p = 0.934).Conclusion: The use of SG induces a TFSQ-BUT reduction, with these changes returning to baseline levels immediately after SG removal. These data may be of relevance for the management of dry eye patients, who need to avoid circumstances that exacerbate tear film instability. Nevertheless, these results must be interpreted with caution since the experiment did not entirely mimic real-life conditions (e.g., eye cup piece drilled, time of exposure, environmental conditions). Future studies should consider the inclusion of dry eye patients and older individual in order to explore the generalizability of these findings. (AU)


Subject(s)
Humans , Male , Female , Adult , Xerophthalmia/prevention & control , Dry Eye Syndromes , Eye Protective Devices , Swimming , Tears
2.
Nutrients ; 10(3)2018 02 28.
Article in English | MEDLINE | ID: mdl-29495608

ABSTRACT

The aim of this study was to assess the anti-inflammatory and anti-apoptotic effects of KIOM-2015EW, the hot-water extract of maple leaves in hyperosmolar stress (HOS)-induced human corneal epithelial cells (HCECs). HCECs were exposed to hyperosmolar medium and exposed to KIOM-2015EW with or without the hyperosmolar media. Tumor necrosis factor (TNF)-α, interleukin (IL)-1ß, and IL-6 production and apoptosis were observed, and the activation of mitogen-activated protein kinases (MAPKs) including extracellular signal regulated kinase (ERK), p38 and c-JUN N-terminal kinase (JNK) signaling and nuclear factor (NF)-κB was confirmed. Compared to isomolar medium, the induction of cell cytotoxicity significantly increased in HCECs exposed to hyperosmolar medium in a time-dependent manner. KIOM-2015EW-treatment significantly reduced the mRNA and protein expression of pro-inflammatory mediators and apoptosis. KIOM-2015EW-treatment inhibited HOS-induced MAPK signaling activation. Additionally, the HOS-induced increase in NF-κB phosphorylation was attenuated by KIOM-2015EW. The results demonstrated that KIOM-2015EW protects the ocular surface by suppressing inflammation in dry eye disease, and suggest that KIOM-2015EW may be used to treat several ocular surface diseases where inflammation plays a key role.


Subject(s)
Acer , Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , Epithelium, Corneal/drug effects , Osmotic Pressure , Plant Extracts/pharmacology , Xerophthalmia/prevention & control , Acer/chemistry , Anti-Inflammatory Agents/isolation & purification , Cells, Cultured , Dose-Response Relationship, Drug , Epithelium, Corneal/metabolism , Epithelium, Corneal/pathology , Humans , Inflammation Mediators/metabolism , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Mitogen-Activated Protein Kinases/metabolism , Phosphorylation , Phytotherapy , Plant Extracts/isolation & purification , Plant Leaves , Plants, Medicinal , Signal Transduction/drug effects , Time Factors , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism , Xerophthalmia/etiology , Xerophthalmia/metabolism , Xerophthalmia/pathology
4.
JAMA Ophthalmol ; 132(1): 115-7, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24407830

ABSTRACT

Within 20 years of its discovery 100 years ago, vitamin A was recognized as critical to normal eyes, growth, and survival. Clinical interest subsequently contracted to its importance in preventing xerophthalmia, until this ophthalmologist stumbled, quite accidently, on its role in fighting life-threatening infections. Repeated, large-scale randomized clinical trials eventually convinced (and reminded) the pediatric and nutrition communities of its importance for child survival. Vitamin A distribution programs are now credited with saving the sight and lives of nearly half a million children every year.


Subject(s)
Blindness/history , Vitamin A Deficiency/history , Vitamin A/history , Vitamins/history , Blindness/prevention & control , Developing Countries , History, 20th Century , History, 21st Century , Humans , Vitamin A/administration & dosage , Vitamin A Deficiency/prevention & control , Vitamins/administration & dosage , Xerophthalmia/history , Xerophthalmia/prevention & control
5.
Nepal J Ophthalmol ; 5(2): 226-9, 2013.
Article in English | MEDLINE | ID: mdl-24172559

ABSTRACT

INTRODUCTION: Vitamin A deficiency (VAD) is recognized as a major cause of blindness among children in India. OBJECTIVE: To find out the prevalence of VAD in rural children of Uttar Pradesh, India. MATERIALS AND METHODS: This cross-sectional study was undertaken amongst children (0-15 years) in a rural area of Bareilly (Uttar Pradesh) where the study population was selected by simple random sampling out of villages under a Primary Health Centre. Out of 844 children, 802 participated in the study. The WHO classification of xerophthalmia was used. RESULTS: Overall, the prevalence of xerophthalmia was 5.4 %. The prevalence of Bitot's spots was 0.9 % in children under six years of age and 3.3 % in children above six years. The prevalence of xerophthalmia was significantly more in older children. Overall, the prevalence of anemia was found to be 11.8 % in the study population. A significantly high prevalence of xerophthalmia (OR= 5.7; 95 % CI = 2.8 - 11.5) was observed in children suffering from anemia. CONCLUSION: The presence of a milder manifestation of xerophthalmia and a 0.9 % prevalence of Bitot's spot in children under six years of age in the present study shows a declining trend of VAD although it is still a public health problem. The higher prevalence in children above six years of age shows that apart from strengthening of Vitamin A prophylaxis programs, health education is needed for dietary diversification to include vegetables and fruits in the diet for long-term sustainability in improving the vitamin A status of children of all age groups.


Subject(s)
Rural Population/statistics & numerical data , Vitamin A/administration & dosage , Vitamin D Deficiency/drug therapy , Vitamin D Deficiency/epidemiology , Xerophthalmia/epidemiology , Xerophthalmia/prevention & control , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Male , Prevalence , Severity of Illness Index , Vitamins/administration & dosage
6.
J Public Health Policy ; 34(4): 538-48, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23760134

ABSTRACT

Recently prominent nutrition scientists across the world have opposed continuation of vitamin A supplementation (VAS) programmes and recommended gradual phasing out VAS for pre-school children. A few eminent nutrition scientists in India have echoed this view, arguing that vitamin deficiency (VAD) is no longer a public health problem in India. We review the evidence, highlighting the high rates of VAD among pre-school children in India, (clinical, subclinical, and dietary deficiency) and argue that in India VAD remains an immensely important public health problem and it is crucial to strengthen and continue the existing VAS programme in India, and in other developing countries until such time as their children's dietary consumption of vitamin A is improved adequately and blood vitamin A levels reach optimal levels.


Subject(s)
Public Policy , Vitamin A Deficiency/prevention & control , Vitamin A/therapeutic use , Vitamins/therapeutic use , Developing Countries , Humans , India/epidemiology , Prevalence , Vitamin A Deficiency/epidemiology , Xerophthalmia/epidemiology , Xerophthalmia/prevention & control
8.
Public Health Nutr ; 15(7): 1201-15, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22401130

ABSTRACT

OBJECTIVE: Developing countries have adopted universal, high-potency vitamin A (VA) supplementation and food fortification as major strategies to control deficiency, prevent nutritional blindness and reduce child mortality. Yet questions persist regarding how best to measure impact and when to phase out supplementation. The present paper provides guidance on the use and interpretation of serum retinol (SROL) distributions as indicators of both programme impact and adequate VA intake in a population. DESIGN: We reviewed extant data on SROL's response to high-potency VA supplementation and VA-fortified foods in children. RESULTS: Supplementation virtually eliminates xerophthalmia and reduces child mortality; however, it shifts the SROL distribution only transiently (<2 months). Regular consumption of VA-fortified foods prevents xerophthalmia, lowers mortality and sustainably improves SROL distributions, from which both compliance and public health impact can be inferred. CONCLUSIONS: Given SROL's limited responsiveness to high-potency VA supplementation, target population coverage remains the preferred performance indicator. However, periodic SROL surveys do reflect underlying dietary risk and can guide programming: low or marginal SROL distributions in areas with high supplementation coverage do not signify programme failure, but rather suggest the need to continue supplementation while working to effectively raise dietary VA intakes. We propose that a sustained rise in the SROL distribution, defined as ≤5 % prevalence of SROL < 0·70 µmol/l among vulnerable population groups in at least two consecutive surveys (≥1 year apart), be used as an indicator of stable and adequate dietary VA intake and status in a population, at which point programmes may re-evaluate the need for continued universal supplementation.


Subject(s)
Dietary Supplements , Food, Fortified , Vitamin A Deficiency/epidemiology , Vitamin A Deficiency/prevention & control , Vitamin A/administration & dosage , Vitamin A/blood , Child, Preschool , Databases, Factual , Guidelines as Topic , Humans , Infant , Public Health , Randomized Controlled Trials as Topic , Risk Factors , Vitamin A Deficiency/complications , Xerophthalmia/etiology , Xerophthalmia/prevention & control
9.
BMJ ; 343: d5094, 2011 Aug 25.
Article in English | MEDLINE | ID: mdl-21868478

ABSTRACT

OBJECTIVE: To determine if vitamin A supplementation is associated with reductions in mortality and morbidity in children aged 6 months to 5 years. DESIGN: Systematic review and meta-analysis. Two reviewers independently assessed studies for inclusion. Data were double extracted; discrepancies were resolved by discussion. Meta-analyses were performed for mortality, illness, vision, and side effects. DATA SOURCES: Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Medline, Embase, Global Health, Latin American and Caribbean Health Sciences, metaRegister of Controlled Trials, and African Index Medicus. Databases were searched to April 2010 without restriction by language or publication status. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised trials of synthetic oral vitamin A supplements in children aged 6 months to 5 years. Studies of children with current illness (such as diarrhoea, measles, and HIV), studies of children in hospital, and studies of food fortification or ß carotene were excluded. RESULTS: 43 trials with about 215,633 children were included. Seventeen trials including 194,483 participants reported a 24% reduction in all cause mortality (rate ratio=0.76, 95% confidence interval 0.69 to 0.83). Seven trials reported a 28% reduction in mortality associated with diarrhoea (0.72, 0.57 to 0.91). Vitamin A supplementation was associated with a reduced incidence of diarrhoea (0.85, 0.82 to 0.87) and measles (0.50, 0.37 to 0.67) and a reduced prevalence of vision problems, including night blindness (0.32, 0.21 to 0.50) and xerophthalmia (0.31, 0.22 to 0.45). Three trials reported an increased risk of vomiting within the first 48 hours of supplementation (2.75, 1.81 to 4.19). CONCLUSIONS: Vitamin A supplementation is associated with large reductions in mortality, morbidity, and vision problems in a range of settings, and these results cannot be explained by bias. Further placebo controlled trials of vitamin A supplementation in children between 6 and 59 months of age are not required. However, there is a need for further studies comparing different doses and delivery mechanisms (for example, fortification). Until other sources are available, vitamin A supplements should be given to all children at risk of deficiency, particularly in low and middle income countries.


Subject(s)
Night Blindness/prevention & control , Vitamin A Deficiency/prevention & control , Vitamin A/therapeutic use , Bias , Child Mortality , Child, Preschool , Developing Countries , Diarrhea/epidemiology , Diarrhea/prevention & control , Female , Humans , Infant , Infant Mortality , MEDLINE , Male , Measles/epidemiology , Measles/prevention & control , Morbidity , Mortality , Night Blindness/epidemiology , Primary Prevention/methods , Randomized Controlled Trials as Topic , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/prevention & control , Vitamin A Deficiency/drug therapy , Vitamin A Deficiency/epidemiology , Vomiting/epidemiology , Vomiting/prevention & control , Xerophthalmia/epidemiology , Xerophthalmia/prevention & control
10.
Facial Plast Surg ; 27(1): 58-66, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21246457

ABSTRACT

Blepharoplasty is one of the most popular and common procedures in facial plastic surgery. Initially performed in 1818 for eyelid reconstruction, blepharoplasty has evolved to become a cosmetic or functional operation. Although the surgical approaches are relatively straightforward, achieving natural and predictable results require precision and judgment. After performing more than 3500 blepharoplasties, the senior author has learned that the "art of blepharoplasty" has less to do with how much skin or fat is removed and is more about understanding the anatomic changes associated with aging, developing an individualized surgical plan, and anticipating postoperative outcomes or complications.


Subject(s)
Blepharoplasty/methods , Aging/pathology , Blepharoplasty/classification , Cosmetic Techniques , Eyebrows/anatomy & histology , Eyelids/pathology , Facial Muscles/pathology , Humans , Nose/anatomy & histology , Patient Care Planning , Postoperative Complications/prevention & control , Preoperative Care , Plastic Surgery Procedures , Rejuvenation , Rhytidoplasty , Treatment Outcome , Xerophthalmia/prevention & control
12.
Zhonghua Yan Ke Za Zhi ; 44(11): 1011-9, 2008 Nov.
Article in Chinese | MEDLINE | ID: mdl-19176098

ABSTRACT

OBJECTIVE: To assess the preventive effects of extract of Buddleja officinalis on dry eye in castrated rabbits and to discuss the mechanism of these effects. METHODS: It was a experimental study. Thirty male rabbits were divided equally into normal group (A), disease group (B) and treatment group (C, D, and E). The dry eye model was established with orchiectomy (ORX) in Group B, C, D and E. Group C, D and E were gastrically perfused with single-dose or double-does of Buddleja officinalis extract or genistein for 30 days. All rabbits were examined with Schirmer I test (SIT). TGF-beta1, IL-1beta, TNF-alpha, Fas, FasL, Bax and bcl-2 were detected by immunohistochemistry. Morphological and ultrastructure changes were observed by electron microscopy. RESULTS: The SIT value of group C, D, E was significantly greater than that of group B (P < 0.01). The expression of IL-1beta, TNF-alpha, Fas, FasL and Bax in acinar cells and glandular tube cells of group C, D, E were significantly lower than those of group B (P < 0.01) and the expression of TGF-beta1 and bcl-2 in acinar cells and glandular tube cells of group C, D, E were significantly higher than those of group B (P < 0.01). Furthermore, ultrastructure of lacrimal gland in group C, D, E was much healthier than that of group B. The results obtained from all of these studies showed that the lacrimal glands status in group C, D was significantly better than that of group E (P < 0.05). CONCLUSION: Extract of Buddleja officinalis has a significant effect on the prevention of experimental dry eye in castrated male rabbits. The main components of extract of Buddleja officinalis are the flavonoids. The flavonoids display androgen-like activity. Therefore, it can adjust gonadal hormone level in vivo. As a result, it can inhibit local inflammation in lacrimal gland and reduce apoptosis of lacrimal gland cells.


Subject(s)
Buddleja/chemistry , Flavones/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Xerophthalmia/drug therapy , Animals , Lacrimal Apparatus/drug effects , Male , Rabbits , Xerophthalmia/prevention & control
13.
Clin Ter ; 158(5): 453-6, 2007.
Article in English | MEDLINE | ID: mdl-18062353

ABSTRACT

The Sjogren's syndrome (SS) is an chronic inflammatory autoimmune disease of the exocrine glands as well as of internal apparatus. The therapy of exocrinopathy is represented by parasympathomimetic drugs such as pilocarpine and cevimeline. The therapy of systemic manifestations, actually is represented by the inhibitors of TNF alfa, as well as leflunomide, methotrexate and cyclosporine-A, but the results are quite insufficient and disappointed. In order to the involvement of B-cell function in the pathogenesis of SS, one of the most important option in the future should be specific inhibitors of that cells.


Subject(s)
B-Lymphocytes , Immunosuppressive Agents/therapeutic use , Parasympathomimetics/therapeutic use , Sjogren's Syndrome/drug therapy , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antibodies, Monoclonal, Murine-Derived , B-Lymphocytes/drug effects , Cyclosporine/therapeutic use , Etanercept , Humans , Immunoglobulin G/therapeutic use , Infliximab , Isoxazoles/therapeutic use , Leflunomide , Methotrexate/therapeutic use , Muscarinic Agonists/therapeutic use , Pilocarpine/therapeutic use , Quinuclidines/therapeutic use , Receptors, Tumor Necrosis Factor/therapeutic use , Rituximab , Sjogren's Syndrome/complications , Sjogren's Syndrome/physiopathology , Thiophenes/therapeutic use , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Xerophthalmia/prevention & control , Xerostomia/prevention & control
14.
Indian J Pediatr ; 74(5): 443-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17526954

ABSTRACT

OBJECTIVE: To study the impact of mass supplementation of Vitamin A solution on morbidity due to diarrhea, Acute respiratory infection (ARI) and xerophthalmia. METHODS: The two rounds of age specific mass distribution of Vitamin A solution were undertaken during January 2000 and December 2000 respectively covering 27,642 (98.7%) and 31,762 (88.0%) children respectively out of total beneficiaries in two round of PPI in Chandigarh. A random sample of 276 children from intervention area and 252 children from control area in the age group of 1-5 yr were followed up on monthly basis for morbidity pattern for a period of nine mth. The morbidity pattern for intervention and control area children was compared to see the impact of mass supplementation of Vitamin A solution. RESULTS: The average annual episodes of diarrhea in intervention children were lower (3.9 per yr) as compared to control children (5.2 per yr) although difference was not statistically significant (P>0.05) except in initial month. The average annual episodes of ARI in intervention children were lower (5.1 per yr) as compared to Control children (6.0 per yr) although difference was not significant (P>0.05) except in initial first mth. There was significant decline in vitamin A deficiency (VAD) as no case of Bitot's spot was found in intervention children as compared to control children where the prevalence of Bitot's spot ranged from 4.3-5.08% during different visits. The mortality rate was found to be higher in control children with a death rate of 8 per 1000 children during the study period as compared to intervention children where no death was recorded. CONCLUSION: It is concluded that mass supplementation of vitamin A led to significant reduction in xerophthalmia and decline in mortality in the intervention area as compared to control area.


Subject(s)
Vitamin A Deficiency/prevention & control , Vitamin A/therapeutic use , Child, Preschool , Diarrhea/epidemiology , Dietary Supplements , Female , Humans , India/epidemiology , Infant , Male , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/prevention & control , Urban Population , Xerophthalmia/epidemiology , Xerophthalmia/prevention & control
15.
Klin Monbl Augenheilkd ; 223(5): 443-6, 2006 May.
Article in English | MEDLINE | ID: mdl-16705527

ABSTRACT

BACKGROUND: Rapidly progressing bilateral night blindness in an elderly patient suggests primarily a diagnosis of paraneoplastic retinopathy. Occasionally diffuse rod dysfunction can result from vitamin A deficiency. HISTORY AND SIGNS: A 70-year-old man complained of progressive night blindness and xanthopsia for the past 6 months. Visual acuity was 0.8 in both eyes with severe dyschromatopsia. Slit-lamp and fundus examination were normal. Visual field disclosed bilateral depression. Scotopic full-field ERG was severely reduced. The patient's medical history revealed an acute pancreatitis one year ago, followed by chronic jaundice and an increased blood bilirubin. Serum vitamin A level was decreased to 0.1 micromol/L (normal range 1.5 to 4.0). THERAPY AND OUTCOME: Intramuscular injections of vitamin A were provided. Subjective visual improvement was reported already one day after initiation of therapy. Scotopic full-field ERG was markedly improved 3 days after the injection and was only slightly subnormal 3 months later. CONCLUSIONS: In developed countries, vitamin A deficiency usually results from malabsorption syndromes and manifests initially by rod more than cone dysfunction. This diagnosis should be entertained early as vitamin A supplementation induces a rapid restoration of vision.


Subject(s)
Color Vision Defects/prevention & control , Malabsorption Syndromes/drug therapy , Night Blindness/prevention & control , Pigmentation Disorders/prevention & control , Vitamin A Deficiency/drug therapy , Vitamin A/administration & dosage , Xerophthalmia/prevention & control , Aged , Humans , Malabsorption Syndromes/diagnosis , Male , Skin Pigmentation
16.
Zhonghua Yan Ke Za Zhi ; 42(2): 159-61, 2006 Feb.
Article in Chinese | MEDLINE | ID: mdl-16643733

ABSTRACT

OBJECTIVE: To investigate tear film changes after recovery from acute conjunctivitis. METHODS: This study involved 73 eyes of 56 consecutive patients who had recovered from acute conjunctivitis after routine treatment in Zhongshan Ophthalmic Center between July 2002 and August 2003. Excluded other factors which could affect the stability of the tear film, tear film break up time (BUT), Schirmer I test (ST), fluorescein staining (FL) and the height of tear meniscus were measured on both recovered and healthy eyes of the patients at 3, 7, 14, 21 and 30 days after recovery. RESULTS: BUT was 14.72 s in healthy eyes, 5.23, 5.11, 7.84, 10.26 and 12.74 s in recovered eyes at 3, 7, 14, 21 and 30 days (P = 0.012, 0.018, 0.032, 0.028 and 0.122), respectively. FL scored at 2.26 in healthy eyes, 3.02, 6.23, 7.92, 6.37 and 3.53 at 3, 7, 14, 21 and 30 days in recovered eyes (P = 0.063, 0.017, 0.008, 0.024 and 0.074), respectively. ST scored at 16.30 mm in healthy eyes, 9.39, 11.48, 13.85, 21.24 and 17.40 mm, at 3, 7, 14, 21 and 30 days in recovered eyes (P = 0.025, 0.040, 0.082, 0.012 and 0.104), respectively. The height of tear meniscus was 0.62 mm in healthy eyes; it scored at 0.39, 0.32, 0.44, 0.53 and 0.58 mm at 3, 7, 14, 21 and 30 days in recovered eyes (P = 0.008, 0.015, 0.037, 0.120 and 0.182), respectively. CONCLUSIONS: Instability of tear film and transient dry eye can occur after recovery from acute conjunctivitis. However, dry eye can be avoided during the treatment of acute conjunctivitis by consideration of drug side effects to the tear film and minimizing the unnecessary use of drugs.


Subject(s)
Conjunctivitis/physiopathology , Tears/physiology , Acute Disease , Adolescent , Adult , Conjunctiva/pathology , Conjunctivitis/drug therapy , Conjunctivitis/pathology , Female , Humans , Male , Middle Aged , Xerophthalmia/prevention & control
17.
J Indian Med Assoc ; 103(3): 180, 182-3, 2005 Mar.
Article in English | MEDLINE | ID: mdl-16173295

ABSTRACT

To study the correlation of stages of xerophthalmia in different grades of malnutrition, having 200 children clinically diagnosed having malnutrition as per criteria laid down by the Indian Academy of Pediatrics (IAP) were examined to detect the dinical stages of xerophthalmia as proposed by World Health Organisation (WHO). Out of 200 cases with different grades of malnutrition 81 (40.5%), 78 (39.0%), 22 (11.0%) and 19 (9.5%) were found malnourished in grades I, II, III, and IV respectively. Night blindness was earliest feature and seen in 97 cases (48.5%). All the 97 cases of night blindness fell in group of X(N) in which one case had corneal scar and falls in the group of X(S) in clinical staging of xerophthalmia. Thirty-nine (40.2%), 35 (36.1%), 19 (19.6%), 3 (3.1%) and (1.1%) were in clinical stages of xerophthalmia of X(1A), X(1B), X2, X(3A), X(3B)respectively. Severity of xerophthalmia was found directly proportional to severity of malnutrition.


Subject(s)
Child Nutrition Disorders/epidemiology , Vitamin A Deficiency/epidemiology , Xerophthalmia/epidemiology , Body Weight , Child , Child Nutrition Disorders/classification , Child, Preschool , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Male , Severity of Illness Index , Vitamin A Deficiency/prevention & control , Xerophthalmia/pathology , Xerophthalmia/prevention & control
18.
Can J Anaesth ; 51(2): 126-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14766687

ABSTRACT

PURPOSE: Anesthesia impairs lid closure and decreases tear secretion and stability. Protection may, in principle, be conveyed by manual eye closure, taping the eyelids closed, and by instillation of protective substances into the conjunctival sac. Both hydro-gels and ointments are used in clinical practice. It was the objective of the present study to compare a transparent clear ocular hydro-gel (Vidisic) and a commonly used dexpanthenol and vitamin A (Oleovit) based ointment as examples of these classes of ocular lubricants in their capability to provide perioperative eye comfort. Furthermore, their bacteriostatic properties were assessed in vitro. METHODS: Ninety-two consecutive patients undergoing total iv general anesthesia were randomly allocated to receive either ocular dexpanthenol ointment or a clear hydro-gel after induction of anesthesia. Subjects were assessed one hour following termination of anesthesia. RESULTS: Main findings were an increased incidence of foreign body sensation, adherent eyelashes and disturbance elicited by blurred vision in the ointment group as compared to clear hydro-gel (P < 0.001). Bacterial growth was significantly attenuated by the ocular hydro-gel as compared to ointment. DISCUSSION: Clear ocular hydro-gel offers improved patient comfort and decreased ocular inflammation as compared to conventional eye ointments. In addition, it decreases bacterial growth. Therefore, the use of clear ocular hydro-gel for perioperative ocular comfort is suggested.


Subject(s)
Acrylates/therapeutic use , Anesthesia, General/adverse effects , Eye/drug effects , Pantothenic Acid/analogs & derivatives , Pantothenic Acid/therapeutic use , Vitamin A/therapeutic use , Xerophthalmia/prevention & control , Chi-Square Distribution , Colony Count, Microbial , Eye/physiopathology , Female , Humans , Hydrogels/therapeutic use , In Vitro Techniques , Male , Middle Aged , Neurosurgical Procedures/adverse effects , Ointments , Postoperative Complications/prevention & control , Staphylococcus aureus/drug effects , Time Factors , Urologic Surgical Procedures/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...